COMPARATIVE ANALYSIS OF TABLETS, FROM FORMAL AND INFORMAL MARKET, CONTAINING SILDENAFIL CITRATE

Authors

  • Jonathan Parisotto Peterle Laboratório de Química Farmacêutica (Sala 515, Bloco S), Centro de Ciências Biológicas e da Saúde (CCBS), Faculdade de Farmácia, Universidade de Caxias do Sul (UCS), Rua Francisco Getúlio Vargas, 1.130, Bairro Petrópolis, CEP 95070-560, Caxias do Sul, RS. http://orcid.org/0000-0002-7225-3416
  • Francie Bueno Laboratório de Química Farmacêutica (Sala 515, Bloco S), Centro de Ciências Biológicas e da Saúde (CCBS), Faculdade de Farmácia, Universidade de Caxias do Sul (UCS), Rua Francisco Getúlio Vargas, 1.130, Bairro Petrópolis, CEP 95070-560, Caxias do Sul, RS.

DOI:

https://doi.org/10.14450/2318-9312.v28.e4.a2016.pp226-233

Keywords:

sildenafil citrate, quality control, Public Health

Abstract

The sildenafil citrate is a selective inhibitor of the enzyme phosphodiesterase type 5 (PDE5 inhibitor), restoring erectile function of the penis. The aim of this study was to make a comparative analysis of visual appearance, average
weight and content uniformity among the drugs available in the formal and informal markets, by spectrophotometry in the visible region of 535 nm. Analyzing the obtained results, the reference, generic and similar
medicines presented primary and secondary packaging, drug label, intact security seal, homogeneous blue tablets and white core, differing only in format. Meanwhile, the medicine acquired in the informal market, just presented the primary packaging, with heterogeneous blue tablets and irregular format. The reference, generic, similar and informal market medicines, presented respectively, average weight values of 316.3 mg ± 0.0069, 318.0 mg
± 0.0053, 348.2 mg ± 0.0044 and 140.1 mg ± 0.0047, following the determinations of the Brazilian Pharmacopoeia. In the uniformity content test, only the reference, generic and similar, with content values respectively of
103.1% ± 0.5297, 103.9% ± 0.6420 and 100.0% ± 0.8028, fulfilled specifications, while the sample of informal market presented content of 63.7% ± 3,530, not fulfilling determinations of Brazilian legislation. Thus, is noted by this study the great health risk to patients when using the dubious origin of drugs.

Author Biographies

Jonathan Parisotto Peterle, Laboratório de Química Farmacêutica (Sala 515, Bloco S), Centro de Ciências Biológicas e da Saúde (CCBS), Faculdade de Farmácia, Universidade de Caxias do Sul (UCS), Rua Francisco Getúlio Vargas, 1.130, Bairro Petrópolis, CEP 95070-560, Caxias do Sul, RS.

Farmacêutico, formado em Farmácia pela Universidade de Caxias do Sul (2015), Mestrando em Ciências Farmacêuticas, área de Tecnologia Farmacêutica, pelo Programa de Pós-Graduação da Universidade Federal do Rio Grande do Sul (UFRGS) (2015-2017)

Francie Bueno, Laboratório de Química Farmacêutica (Sala 515, Bloco S), Centro de Ciências Biológicas e da Saúde (CCBS), Faculdade de Farmácia, Universidade de Caxias do Sul (UCS), Rua Francisco Getúlio Vargas, 1.130, Bairro Petrópolis, CEP 95070-560, Caxias do Sul, RS.

Farmacêutica, mestre em Ciências Farmacêuticas pelo Programa de Pós-Graduação da Universidade Federal do Rio Grande do Sul (UFRGS) e docente do curso de farmácia da Universidade de Caxias do Sul (UCS), nas áreas de Química Farmacêutica, Química Analítica e Controle de Qualidade de Medicamentos

Downloads

Published

2016-12-27

How to Cite

Parisotto Peterle, J., & Bueno, F. (2016). COMPARATIVE ANALYSIS OF TABLETS, FROM FORMAL AND INFORMAL MARKET, CONTAINING SILDENAFIL CITRATE. Infarma - Pharmaceutical Sciences, 28(4), 226–233. https://doi.org/10.14450/2318-9312.v28.e4.a2016.pp226-233

Issue

Vol. 28 No. 4 (2016)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).